# Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

> **NCT00710593** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 99 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **BIOLOGICAL:** HPV vaccine for strains -6, -11, -16, and -18

## Key facts

- **NCT ID:** NCT00710593
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710593, "Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00710593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*